NextPlat Corp (NASDAQ: NXPL) reported first quarter 2025 financial results showing a revenue of $14.5 million, a decline from $17.5 million in the same period last year. The company attributed the decrease to changes in 340B pharmacy agreements and reduced prescription volume.
Despite the revenue drop, NextPlat demonstrated strategic strength in several key areas. Gross margin settled at 23.8%, while operating expenses decreased by 26% to $4.9 million, primarily due to reduced legal and non-recurring costs. The company narrowed its net loss to $1.3 million, or ($0.05) per share.
The company's e-commerce strategy showed promising signs of growth. NextPlat reported a 51% increase in recurring airtime revenue and expanded its international market presence, notably growing OPKO product sales in China. The company concluded the quarter with $17.7 million in cash, indicating financial stability.
Management remains committed to focusing on high-margin services and strategic healthcare sector expansion. The results suggest NextPlat is navigating challenging market conditions by optimizing operational efficiency and exploring new revenue streams in technology and healthcare markets.
